Biotech ETFs: A Short-Lived Boon From Biogen

Biogen’s initial share price surge helped to lift the bio biotech exchange-traded funds at a clip that dramatically outpaced the broader market.

Advertisements
Biotech ETFs: A Short-Lived Boon From Biogen

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s